- Be randomly assigned to one of the two non-surgical treatment groups - the levonogestrel intrauterine system (LNG-IUS) or combined oral contraceptives.
- Be asked to complete a questionnaire and a diary that includes your period cycle, medical history, and background information.
- Continue with recommended clinical care with your own ob/gyn provider.
- Be asked to complete up to six questionnaires over a one year period.
- Study participation is voluntary
- Participants will be compensated
Heavy menstrual bleeding, or having heavy periods, is a major problem for many women. Women with heavy periods may suffer lessened quality of life, may have to spend time out of work, and may have to cancel plans with family and friends because of their symptoms. Health care providers want to help women get the best treatments for their heavy periods. We want to help women get the best treatments for their heavy bleeding.
What is SHiPP?
Researchers at Women & Infants Hospital are conducting a study on women who have heavy periods. The National Institutes of Health sponsored research project is called SHiPP - or Stopping Heavy Periods Project.
In the United States, the two most common non-surgical treatment options are the levonogestrel intrauterine system (LNG-IUS) and combined oral contraceptives. Researchers seek to determine which of these two treatment options is more effective in improving quality of life for women with heavy or irregular menstrual bleeding.
From left to right, the Stopping Heavy Periods Team includes Cheryl Souza, Research Assistant , Mayelin Pacheco, Research Assistant, Tracey Ferreira, Project Coordinator, Liliana Tavarez, Research Assistant, Dr. Kristen A. Matteson, Primary Investigator
Kristen Matteson, MD, MPH Principal Invesitgator